Article ; Online: Genomics, Transcriptomics, and Epigenetics of Sporadic Pituitary Tumors.
2023 Volume 54, Issue 8, Page(s) 102915
Abstract: Pituitary tumors (PT) are highly heterogeneous neoplasms, comprising functioning and nonfunctioning lesions. Functioning PT include prolactinomas, causing amenorrhea-galactorrhea in women and sexual dysfunction in men; GH-secreting adenomas causing ... ...
Abstract | Pituitary tumors (PT) are highly heterogeneous neoplasms, comprising functioning and nonfunctioning lesions. Functioning PT include prolactinomas, causing amenorrhea-galactorrhea in women and sexual dysfunction in men; GH-secreting adenomas causing acromegaly-gigantism; ACTH-secreting corticotrophinomas causing Cushing disease (CD); and the rare TSH-secreting thyrotrophinomas that result in central hyperthyroidism. Nonfunctioning PT do not result in a hormonal hypersecretion syndrome and most of them are of gonadotrope differentiation; other non-functioning PT include null cell adenomas and silent ACTH-, GH- and PRL-adenomas. Less than 5% of PT occur in a familial or syndromic context whereby germline mutations of specific genes account for their molecular pathogenesis. In contrast, the more common sporadic PT do not result from a single molecular abnormality but rather emerge from several oncogenic events that culminate in an increased proliferation of pituitary cells, and in the case of functioning tumors, in a non-regulated hormonal hypersecretion. In recent years, important advances in the understanding of the molecular pathogenesis of PT have been made, including the genomic, transcriptomic, epigenetic, and proteomic characterization of these neoplasms. In this review, we summarize the available molecular information pertaining the oncogenesis of PT. |
---|---|
MeSH term(s) | Male ; Pregnancy ; Humans ; Female ; Pituitary Neoplasms/genetics ; Pituitary Neoplasms/pathology ; Proteomics ; Adenoma/genetics ; Adenoma/pathology ; Genomics ; Adrenocorticotropic Hormone/genetics ; Adrenocorticotropic Hormone/metabolism ; Gene Expression Profiling ; Epigenesis, Genetic |
Chemical Substances | Adrenocorticotropic Hormone (9002-60-2) |
Language | English |
Publishing date | 2023-11-18 |
Publishing country | United States |
Document type | Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 1156844-6 |
ISSN | 1873-5487 ; 0188-4409 ; 0188-0128 |
ISSN (online) | 1873-5487 |
ISSN | 0188-4409 ; 0188-0128 |
DOI | 10.1016/j.arcmed.2023.102915 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 1001: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.